In cattle, the metabolite neospiramycin, the demycarosyl derivative, is formed. Concentrations of neospiramycin in muscle and kidney were marginally higher than those of spiramycin 14-28 days after dosing; in muscle, levels of neospiramycin and spiramycin were approximately equal.
来源:Hazardous Substances Data Bank (HSDB)
代谢
spiramycin在肝脏中代谢为活性代谢物；大量通过胆汁排出，约10%通过尿液排出。
Spiramycin is metabolized in the liver to active metabolites; substantial amounts are excreted in the bile and about 10% in the urine.
IDENTIFICATION AND USE: Spiramycin is a macrolide antibiotic used for the treatment and control of a number of bacterial and mycoplasmal infections in animals. It is available as a spiramycin embonate for use in animal feed, and as the adipate, a more soluble form, for administration by other routes. It has also been used in the protozoal infections cryptosporidiosis and toxoplasmosis. HUMAN EXPOSURE AND TOXICITY: Spiramycin is reported to cause contact dermatitis in occupational settings. A man who worked in a feed factory developed allergic contact dermatitis due to airborne spiramycin. The patient suffered recurrent outbreaks of eczematous lesions on uncovered areas during working periods. Spiramycin is also reported to cause hypersensitivity reactions. Rhinoconjunctivitis and spasmodic cough are reported in a 34 year-old female handling spiramycin powder in a pharmaceutical factory. The symptoms appeared within the first few hours of coming into contact with the drug and continued for several hours after leaving her place of work. One year after starting work in the pharmaceutical industry a 35-year-old non-atopic maintenance engineer developed attacks of sneezing, coughing and breathlessness. Inhalation challenge tests carried out in the hospital with gradually increasing quantities of spiramycin reproduced his symptoms and led to the development of late asthmatic reactions. Additionally, two cases of bronchial asthma due to spiramycin in workers of a pharmaceutical factory were reported. The subjects complained of cough, breathlessness and symptoms of asthma at work when coming into contact with spiramycin's powder. The symptoms cleared when away from work for more than 3 or 4 days. ANIMAL STUDIES: Groups of 2 male and 2 female monkeys (Macaca fascicularis) were given daily intravenous injections of 0, 240,000, 360,000, and 540,000 iu/kg bw/day spiramycin adipate for 5 days. Hypersalivation occurred during injection in all dose groups. Muscle hypotonia and nauseous spasticity occurred in several high dose monkeys and in one given the low dose. No abnormalities of body weights occurred but food consumption was reduced in all treated animals. A slight decrease in hemoglobin, red cell numbers and hematocrit was noted in high dose animals. In a short-term dietary study in which rats were given the equivalent of up to 3900 mg/kg bw for 13 weeks, the only major effects noted were a reduction in neutrophil counts in some mid- and high-dose animals, and the dilatation of the caecum. In another dietary study in the rat, animals were given up to the equivalent of 720 mg/kg bw/day for one year. The only notable effects were reductions in the body weights of females receiving the high doses, and increases in relative liver, kidney, and adrenal weights at high dose levels in animals of both sexes. Hepatic glycogen depletion occurred at all dose levels but not in controls. In mongrel dogs given 500 mg/kg bw/day for up to 56 days, reductions in spermatogenesis and testicular atrophy occurred. Kidney damage was also seen. When beagles were given orally spiramycin at up to the equivalent of 150 mg/kg bw/day for two years, testicular damage was not seen although degenerative changes occurred in other organs. In teratogenicity studies in mice, oral doses of spiramycin of up to 400 mg/kg bw given over days 5-15 of gestation had no effects on the outcome of pregnancy. intravenous doses of up to 84 mg/kg bw/day given on days 6-15 of gestation to rats and day 6-19 to rabbits had no effect on developmental, but oral dose of 200 and 400 mg/kg bw/day in rabbit produced caecal enlargement in mothers. Groups of 20 pregnant rats were treated intravenously on days 6-15 of gestation with doses of 0, 90 000, 180 000, and 270 000 iu/kg bw/day with spiramycin adipate. The highest dose given produced brief (5 minutes) ataxia and tremors immediately after dosing. A slight but significant reduction in fetal weight occurred at the intermediate dose but all values were within historical control ranges. There were no increased incidences of any fetal anomaly noted in this study. In a study where male rats were given doses of 30 mg/kg bw/day for 8 days by an unspecified route, mitotic and meiotic abnormalities in spermatogonia were noted. Negative result were obtained with spiramycin adipate and embonate in a forward-mutation test in mammalian cells in vitro, in an in vitro cytogenic assay, and in the mouse micronucleus test.
The macrolide antibiotics include natural members, prodrugs & semisynthetic derivatives. These drugs are indicated in a variety of infections & are often combined with other drug therapies, thus creating the potential for pharmacokinetic interactions. Macrolides can both inhibit drug metab in the liver by complex formation & inactivation of microsomal drug oxidising enzymes & also interfere with microorganisms of the enteric flora through their antibiotic effects. Over the past 20 yrs, a number of reports have incriminated macrolides as a potential source of clinically severe drug interactions. However, differences have been found between the various macrolides in this regard & not all macrolides are responsible for drug interactions. With the recent advent of many semisynthetic macrolide antibiotics it is now evident that they may be classified into 3 different groups in causing drug interactions. The first group (e.g. troleandomycin, erythromycins) are those prone to forming nitrosoalkanes & the consequent formation of inactive cytochrome P450-metabolite complexes. The second group (e.g. josamycin, flurithromycin, roxithromycin, clarithromycin, miocamycin & midecamycin) form complexes to a lesser extent & rarely produce drug interactions. The last group (e.g. spiramycin, rokitamycin, dirithromycin & azithromycin) do not inactivate cytochrome P450 & are unable to modify the pharmacokinetics of other cmpds. It appears that 2 structural factors are important for a macrolide antibiotic to lead to the induction of cytochrome P450 & the formation in vivo or in vitro of an inhibitory cytochrome P450-iron-nitrosoalkane metabolite complex: the presence in the macrolide molecules of a non-hindered readily accessible N-dimethylamino group & the hydrophobic character of the drug. Troleandomycin ranks first as a potent inhibitor of microsomal liver enzymes, causing a significant decr of the metab of methylprednisolone, theophylline, carbamazepine, phenazone (antipyrine) & triazolam. Troleandomycin can cause ergotism in patients receiving ergot alkaloids & cholestatic jaundice in those taking oral contraceptives. Erythromycin & its different prodrugs appear to be less potent inhibitors of drug metab. Case reports & controlled studies have, however, shown that erythromycins may interact with theophylline, carbamazepine, methylprednisolone, warfarin, cyclosporin, triazolam, midazolam, alfentanil, disopyramide & bromocriptine, decreasing drug clearance. The bioavailability of digoxin appears also to be increased by erythromycin in patients excreting high amounts of reduced digoxin metabolites, probably due to destruction of enteric flora responsible for the formation of these cmpds. These incriminated macrolide antibiotics should not be administered concomitantly with other drugs known to be affected metabolically by them, or at the very least, combined admin should be carried out only with careful patient monitoring.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
相互作用
已报告与 spiramycin 同时使用时，左旋多巴的血浆浓度降低。
Reduced plasma concentrations of levodopa have been reported when given with spiramycin.
The authors report the case of a 21 year old woman with a congenital long QT syndrome who had several syncopal attacks at least one of which was caused by torsades de pointes. This sudden complication was attributed to the simultaneous prescription of Spiramycine and Mequitazine over a 48 hour period. These two drugs are not considered to be predisposing factors for torsades de pointes despite the fact that they belong to two families of drugs which can trigger this type of arrhythmia. The withdrawal of this treatment led to the complete regression of the syncopal episodes with a follow-up of two years and a significant shortening of the initial QTc interval which remained, nevertheless, longer than normal. This case underlines the potential risks of drug associations of these two families of drugs, especially in patients with the congenital long QT syndrome.
/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/
Spiramycin is well absorbed in humans after oral administration. Oral administration of 15-30 mg/kg bw to healthy young male adults resulted in peak plasma levels in 3-4 hours and plasma concentrations of 0.96-1.65 mg/l. After intravenous dosing (7.25 mg/kg b.w.) a large volume of distribution (Vdss 5.6 l/kg) was observed indicating extensive tissue distribution. Biotransformation did not appear to be important. Biliary excretion was the main route of excretion; only 7-20% of an oral dose was excreted in the urine. Spiramycin is known to achieve high tissue:serum concentrations in pulmonary and prostatic tissues, and in skin.
Spiramycin crosses the placenta to the fetus. Concns of the antibiotic in maternal serum, cord blood, & the placenta after a dosage regimen of 2 g/day were 1.19 ug/ml, 0.63 ug/ml, & 2.75 ug/ml, respectively. When the maternal dose was increased to 3 g/day, the levels were 1.69 ug/ml, 0.78 ug/ml, & 6.2 ug/ml, respectively. Based on these results, the cord:maternal serum ratio is approx 0.5. Moreover, at these doses, spiramycin is concentrated in the placenta with levels approx 2-4 times those in the maternal serum. ... Spiramycin is excreted into breast milk. Nursing infants of mothers receiving 1.5 g/day for 3 days had spiramycin serum concns of 20 ug/ml. This concn was bacteriostatic.
/MILK/ Spiramycin is a macrolide antibiotic that is active against most of the microorganisms isolated from the milk of mastitic cows. This work investigated the disposition of spiramycin in plasma & milk after iv, intramuscular & subcutaneous admin. Twelve healthy cows were given a single injection of spiramycin at a dose of 30,000 IU/kg by each route. Plasma & milk were collected post injection. Spiramycin concn in the plasma was determined by a high performance liquid chromatography method, & in the milk by a microbiological method. The mean residence time after iv admin was significantly longer (P<0.01) in the milk (20.7 +/- 2.7 h) than in plasma (4.0 +/- 1.6 h). An average milk-to-plasma ratio of 36.5 +/- 15 was calculated from the area concn-time curves. Several pharmacokinetic parameters were examined to determine the bioequivalence of the two extravascular routes. The dose fraction adsorbed after intramuscular or subcutaneous admin was almost 100% & was bioequivalent for the extravascular routes, but the rates of absorption, the max concns & the time to obtain them differed significantly between the two routes. Spiramycin quantities excreted in milk did not differ between the two extravascular routes but the latter were not bioequivalent for max concn in the milk. However, the two routes were bio-equivalent for the duration of time the milk concn exceeded the minimal inhibitory concn (MIC) of various pathogens causing infections in the mammary gland.
Plasma protein binding ranges from 10 to 25%. An oral dose of 6 million units produces peak blood concentrations of 3.3 ug/mL after 1.5 to 3 hours; the half life is about 5 to 8 hours. High tissue concentrations are achieved and persist long after the plasma concentration has fallen to low levels.
![2-[(4R,5S,6S,7R,9R,10R,16R)-6-[(2S,3R,4S,6R)-5-[(2S,4R,5S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde化学式](data:image/svg+xml;base64,<?xml version="1.0" encoding="UTF-8"?>
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="300" height="300" viewBox="0 0 300 300">
<defs>
<g>
<g id="glyph-0-0">
<path d="M 0.359375 1.28125 L 0.359375 -5.140625 L 4 -5.140625 L 4 1.28125 Z M 0.765625 0.875 L 3.59375 0.875 L 3.59375 -4.71875 L 0.765625 -4.71875 Z M 0.765625 0.875 "/>
</g>
<g id="glyph-0-1">
<path d="M 4.6875 -4.90625 L 4.6875 -4.140625 C 4.445312 -4.367188 4.1875 -4.535156 3.90625 -4.640625 C 3.632812 -4.753906 3.347656 -4.8125 3.046875 -4.8125 C 2.441406 -4.8125 1.976562 -4.625 1.65625 -4.25 C 1.332031 -3.882812 1.171875 -3.351562 1.171875 -2.65625 C 1.171875 -1.945312 1.332031 -1.40625 1.65625 -1.03125 C 1.976562 -0.664062 2.441406 -0.484375 3.046875 -0.484375 C 3.347656 -0.484375 3.632812 -0.539062 3.90625 -0.65625 C 4.1875 -0.769531 4.445312 -0.9375 4.6875 -1.15625 L 4.6875 -0.40625 C 4.4375 -0.238281 4.171875 -0.109375 3.890625 -0.015625 C 3.609375 0.0664062 3.3125 0.109375 3 0.109375 C 2.195312 0.109375 1.5625 -0.132812 1.09375 -0.625 C 0.632812 -1.125 0.40625 -1.800781 0.40625 -2.65625 C 0.40625 -3.5 0.632812 -4.164062 1.09375 -4.65625 C 1.5625 -5.15625 2.195312 -5.40625 3 -5.40625 C 3.320312 -5.40625 3.617188 -5.363281 3.890625 -5.28125 C 4.171875 -5.195312 4.4375 -5.070312 4.6875 -4.90625 Z M 4.6875 -4.90625 "/>
</g>
<g id="glyph-0-2">
<path d="M 0.71875 -5.3125 L 1.4375 -5.3125 L 1.4375 -3.125 L 4.046875 -3.125 L 4.046875 -5.3125 L 4.765625 -5.3125 L 4.765625 0 L 4.046875 0 L 4.046875 -2.53125 L 1.4375 -2.53125 L 1.4375 0 L 0.71875 0 Z M 0.71875 -5.3125 "/>
</g>
<g id="glyph-0-3">
<path d="M 2.875 -4.828125 C 2.351562 -4.828125 1.9375 -4.628906 1.625 -4.234375 C 1.320312 -3.847656 1.171875 -3.320312 1.171875 -2.65625 C 1.171875 -1.976562 1.320312 -1.445312 1.625 -1.0625 C 1.9375 -0.675781 2.351562 -0.484375 2.875 -0.484375 C 3.394531 -0.484375 3.804688 -0.675781 4.109375 -1.0625 C 4.410156 -1.445312 4.5625 -1.976562 4.5625 -2.65625 C 4.5625 -3.320312 4.410156 -3.847656 4.109375 -4.234375 C 3.804688 -4.628906 3.394531 -4.828125 2.875 -4.828125 Z M 2.875 -5.40625 C 3.613281 -5.40625 4.207031 -5.15625 4.65625 -4.65625 C 5.101562 -4.15625 5.328125 -3.488281 5.328125 -2.65625 C 5.328125 -1.8125 5.101562 -1.140625 4.65625 -0.640625 C 4.207031 -0.140625 3.613281 0.109375 2.875 0.109375 C 2.125 0.109375 1.523438 -0.140625 1.078125 -0.640625 C 0.628906 -1.140625 0.40625 -1.8125 0.40625 -2.65625 C 0.40625 -3.488281 0.628906 -4.15625 1.078125 -4.65625 C 1.523438 -5.15625 2.125 -5.40625 2.875 -5.40625 Z M 2.875 -5.40625 "/>
</g>
<g id="glyph-0-4">
<path d="M 0.71875 -5.3125 L 1.6875 -5.3125 L 4.03125 -0.875 L 4.03125 -5.3125 L 4.734375 -5.3125 L 4.734375 0 L 3.765625 0 L 1.40625 -4.4375 L 1.40625 0 L 0.71875 0 Z M 0.71875 -5.3125 "/>
</g>
<g id="glyph-1-0">
<path d="M 0.234375 0.859375 L 0.234375 -3.421875 L 2.671875 -3.421875 L 2.671875 0.859375 Z M 0.515625 0.59375 L 2.40625 0.59375 L 2.40625 -3.15625 L 0.515625 -3.15625 Z M 0.515625 0.59375 "/>
</g>
<g id="glyph-1-1">
<path d="M 1.96875 -1.90625 C 2.195312 -1.863281 2.375 -1.765625 2.5 -1.609375 C 2.632812 -1.453125 2.703125 -1.257812 2.703125 -1.03125 C 2.703125 -0.675781 2.582031 -0.40625 2.34375 -0.21875 C 2.101562 -0.03125 1.757812 0.0625 1.3125 0.0625 C 1.164062 0.0625 1.015625 0.046875 0.859375 0.015625 C 0.703125 -0.00390625 0.539062 -0.046875 0.375 -0.109375 L 0.375 -0.5625 C 0.5 -0.488281 0.640625 -0.429688 0.796875 -0.390625 C 0.960938 -0.347656 1.128906 -0.328125 1.296875 -0.328125 C 1.597656 -0.328125 1.828125 -0.382812 1.984375 -0.5 C 2.140625 -0.625 2.21875 -0.800781 2.21875 -1.03125 C 2.21875 -1.238281 2.144531 -1.398438 2 -1.515625 C 1.851562 -1.640625 1.648438 -1.703125 1.390625 -1.703125 L 0.984375 -1.703125 L 0.984375 -2.09375 L 1.421875 -2.09375 C 1.648438 -2.09375 1.828125 -2.140625 1.953125 -2.234375 C 2.078125 -2.328125 2.140625 -2.460938 2.140625 -2.640625 C 2.140625 -2.816406 2.070312 -2.953125 1.9375 -3.046875 C 1.8125 -3.148438 1.628906 -3.203125 1.390625 -3.203125 C 1.265625 -3.203125 1.125 -3.1875 0.96875 -3.15625 C 0.820312 -3.132812 0.660156 -3.09375 0.484375 -3.03125 L 0.484375 -3.453125 C 0.660156 -3.503906 0.828125 -3.539062 0.984375 -3.5625 C 1.148438 -3.59375 1.300781 -3.609375 1.4375 -3.609375 C 1.800781 -3.609375 2.085938 -3.523438 2.296875 -3.359375 C 2.515625 -3.191406 2.625 -2.96875 2.625 -2.6875 C 2.625 -2.488281 2.566406 -2.320312 2.453125 -2.1875 C 2.335938 -2.050781 2.175781 -1.957031 1.96875 -1.90625 Z M 1.96875 -1.90625 "/>
</g>
</g>
</defs>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 7.014927 8.795624 L 7.014927 8.750111 M 7.08513 8.801636 L 7.08513 8.7441 M 7.155547 8.807862 L 7.155547 8.738088 M 7.22575 8.813873 L 7.22575 8.732077 M 7.295953 8.819884 L 7.295953 8.725851 M 7.366155 8.825895 L 7.366155 8.71984 M 7.436358 8.832121 L 7.436358 8.713829 M 7.506561 8.838132 L 7.506561 8.707817 M 7.576763 8.844144 L 7.576763 8.701806 M 7.646966 8.850155 L 7.646966 8.69558 M 7.717169 8.856166 L 7.717169 8.689569 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.945369 8.769647 L 6.74893 9.756993 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.751506 9.750982 L 6.192247 10.588046 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.150597 10.513979 L 5.406278 11.211927 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.243128 10.652667 L 5.313533 11.073239 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.365916 11.140007 L 4.378571 11.336445 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.401328 11.254864 L 3.381564 11.221803 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.36891 11.418241 L 3.413982 11.058426 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.403892 11.142583 L 2.566827 10.583323 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.571335 10.588046 L 2.01229 9.750982 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.014652 9.756993 L 1.818213 8.769647 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.818213 8.776088 L 2.014652 7.788957 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.01229 7.794968 L 2.571335 6.957904 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.566827 6.962412 L 3.403892 6.403367 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.39788 6.405729 L 4.385011 6.20929 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.378571 6.20929 L 5.365916 6.405729 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.359905 6.403367 L 6.19697 6.962412 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.24141 7.031326 L 6.726603 6.546134 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.123547 6.913463 L 6.60874 6.428271 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.192247 6.957904 L 6.567734 7.519739 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.404548 6.142737 L 4.359034 6.142737 M 4.410559 6.075755 L 4.353023 6.075755 M 4.416785 6.008558 L 4.347012 6.008558 M 4.422796 5.94136 L 4.341001 5.94136 M 4.428808 5.874163 L 4.334989 5.874163 M 4.434819 5.806966 L 4.328763 5.806966 M 4.441045 5.739984 L 4.322752 5.739984 M 4.447056 5.672787 L 4.316741 5.672787 M 4.453067 5.60559 L 4.31073 5.60559 M 4.459078 5.538393 L 4.304504 5.538393 M 4.465304 5.471196 L 4.298493 5.471196 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 139.886719 121.96875 L 136.234375 109.980469 L 133.433594 111.140625 L 139.324219 122.199219 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.219046 5.219797 L 3.432874 4.940919 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.538703 6.896718 L 2.505856 6.92978 M 2.496195 6.844763 L 2.453687 6.887272 M 2.453472 6.792595 L 2.401733 6.844549 M 2.41075 6.74064 L 2.349564 6.801826 M 2.368241 6.688471 L 2.297609 6.759318 M 2.325519 6.636517 L 2.24544 6.716595 M 2.283011 6.584348 L 2.193486 6.674087 M 2.240288 6.532394 L 2.141317 6.631365 M 2.19778 6.480225 L 2.089363 6.588642 M 2.155057 6.428271 L 2.037194 6.546134 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 116.027344 101.671875 L 111.554688 113.671875 L 114.484375 114.457031 L 116.613281 101.828125 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.128221 5.294508 L 1.407302 4.573804 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.411811 4.589906 L 1.675661 3.605351 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.663853 3.617159 L 2.638962 3.355885 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.638962 3.355885 L 3.352796 4.069719 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.348502 4.053617 L 3.163657 4.743836 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 138.683594 79.757812 L 151.921875 77.464844 L 151.136719 74.539062 L 138.527344 79.171875 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.638962 3.355885 L 2.821446 2.674683 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 147.945312 44.023438 L 135.019531 46.230469 L 135.804688 49.160156 L 148.101562 44.609375 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.861175 2.140327 L 4.125025 1.155772 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.113218 1.16758 L 5.088541 0.906306 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.088541 0.906306 L 5.802375 1.62014 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.798081 1.604039 L 5.536807 2.579362 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.536807 2.579362 L 4.839289 2.766139 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.536807 2.579362 L 6.018994 3.061549 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 183.25 35.191406 L 196.175781 32.984375 L 195.390625 30.054688 L 183.09375 34.605469 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.158314 0.88591 L 5.131693 0.847696 M 5.218641 0.851775 L 5.184291 0.802612 M 5.278968 0.81764 L 5.236889 0.757528 M 5.339295 0.783505 L 5.289703 0.712443 M 5.399622 0.749369 L 5.342301 0.667574 M 5.459949 0.715234 L 5.395114 0.622489 M 5.520276 0.681099 L 5.447712 0.577405 M 5.580818 0.647178 L 5.50031 0.532321 M 5.641145 0.613043 L 5.553123 0.487451 M 5.701472 0.578908 L 5.605722 0.442367 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 5.088541 0.906306 L 4.800431 0.288651 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.640667 3.549318 L 1.607605 3.582165 M 1.596656 3.495646 L 1.554148 3.538154 M 1.552431 3.442189 L 1.500477 3.493928 M 1.508205 3.388517 L 1.447019 3.449918 M 1.464194 3.33506 L 1.393348 3.405692 M 1.419969 3.281388 L 1.339891 3.361466 M 1.375743 3.227931 L 1.286219 3.317456 M 1.331733 3.174259 L 1.232762 3.27323 M 1.287507 3.120802 L 1.17909 3.229219 M 1.243496 3.067131 L 1.125633 3.184994 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.040832 2.62831 L 1.14839 2.226416 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 0.722021 2.972883 L 0.251213 3.099119 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.338817 4.576595 L 1.35084 4.621679 M 1.267756 4.588618 L 1.283428 4.646583 M 1.196694 4.600855 L 1.215802 4.671701 M 1.125848 4.612877 L 1.148175 4.696605 M 1.054786 4.625114 L 1.080549 4.721723 M 0.983725 4.637137 L 1.013137 4.746627 M 0.912663 4.649374 L 0.945511 4.771746 M 0.841602 4.661396 L 0.877884 4.796649 M 0.770541 4.673634 L 0.810258 4.821768 M 0.699479 4.685656 L 0.742631 4.846671 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.959907 7.746878 L 1.943805 7.785951 M 1.899365 7.717037 L 1.879828 7.764268 M 1.839038 7.687195 L 1.816066 7.742585 M 1.778496 7.657354 L 1.75209 7.720901 M 1.717954 7.627512 L 1.688328 7.699218 M 1.657413 7.597456 L 1.624351 7.677534 M 1.597086 7.567615 L 1.560374 7.656066 M 1.536544 7.537773 L 1.496612 7.634382 M 1.476002 7.507932 L 1.432635 7.612699 M 1.41546 7.47809 L 1.368873 7.591016 M 1.355133 7.448249 L 1.304897 7.569332 M 1.294592 7.418407 L 1.24092 7.547649 M 1.23405 7.388566 L 1.177158 7.525965 M 1.173723 7.358724 L 1.113181 7.504497 M 1.113181 7.328883 L 1.049419 7.482813 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.091283 7.419051 L 0.958392 6.408519 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 0.968482 6.421615 L 0.31841 6.152398 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 0.81584 6.538834 L 0.254433 6.306328 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.939511 9.759355 L 1.957331 9.802507 M 1.871241 9.780394 L 1.894213 9.835783 M 1.802971 9.801433 L 1.831095 9.869274 M 1.7347 9.822473 L 1.767977 9.902551 M 1.666644 9.843512 L 1.704859 9.935827 M 1.598374 9.864551 L 1.641741 9.969318 M 1.530103 9.88559 L 1.578623 10.002595 M 1.461833 9.90663 L 1.515505 10.036086 M 1.393562 9.927669 L 1.452387 10.069363 M 1.325292 9.948708 L 1.389269 10.102639 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.505856 10.615956 L 2.538703 10.649018 M 2.453687 10.658678 L 2.496195 10.701186 M 2.401733 10.701401 L 2.453472 10.753141 M 2.349564 10.743909 L 2.41075 10.80531 M 2.297609 10.786632 L 2.368241 10.857264 M 2.24544 10.82914 L 2.325519 10.909433 M 2.193486 10.871863 L 2.283011 10.961387 M 2.141317 10.914585 L 2.240288 11.013556 M 2.089363 10.957093 L 2.19778 11.06551 M 2.037194 10.999816 L 2.155057 11.117679 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.125645 12.184459 L 2.080561 12.196482 M 2.114052 12.115115 L 2.056087 12.130573 M 2.102459 12.045771 L 2.031612 12.064664 M 2.090651 11.976213 L 2.006923 11.998755 M 2.079058 11.906869 L 1.982449 11.932846 M 2.06725 11.837525 L 1.95776 11.866722 M 2.055657 11.768181 L 1.933286 11.800813 M 2.043849 11.698622 L 1.908597 11.734905 M 2.032256 11.629278 L 1.884122 11.668996 M 2.020448 11.559935 L 1.859433 11.603087 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.128221 12.251441 L 1.407302 12.972146 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.411811 12.956044 L 1.675661 13.940599 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 1.663853 13.928791 L 2.648193 14.192642 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.632092 14.196935 L 3.352796 13.476016 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.348502 13.492118 L 3.163657 12.801899 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.40475 13.522174 L 3.416558 13.478378 M 3.467868 13.54536 L 3.482682 13.489756 M 3.530772 13.568546 L 3.548805 13.501135 M 3.59389 13.591733 L 3.614929 13.512728 M 3.656793 13.614919 L 3.681053 13.524106 M 3.719911 13.63789 L 3.747391 13.535485 M 3.782814 13.661076 L 3.813515 13.547078 M 3.845932 13.684263 L 3.879638 13.558456 M 3.908836 13.707449 L 3.945762 13.569835 M 3.971954 13.730635 L 4.011885 13.581428 M 4.034857 13.753821 L 4.078009 13.592806 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill-rule="nonzero" fill="rgb(0%, 0%, 0%)" fill-opacity="1" d="M 125.445312 263.808594 L 127.621094 276.617188 L 130.550781 275.832031 L 126.03125 263.652344 "/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.679323 15.374494 L 2.415473 15.638129 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 3.141759 15.221422 L 3.612567 15.347443 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 6.805178 8.0717 L 6.945369 8.776088 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.818655 5.100861 L 2.11212 5.290215 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 4.337136 2.60448 L 3.856881 2.124225 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<path fill="none" stroke-width="0.0333333" stroke-linecap="butt" stroke-linejoin="miter" stroke="rgb(0%, 0%, 0%)" stroke-opacity="1" stroke-miterlimit="10" d="M 2.818655 12.445089 L 2.11212 12.255735 " transform="matrix(18.195091, 0, 0, 18.195091, 77.72213, 5.540935)"/>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="219.730469" y="167.816406"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="224.308594" y="167.71875"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="229.304687" y="168.136719"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="200.425781" y="121.976562"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="197.667969" y="149.96875"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="154.585937" y="102.988281"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="159.796875" y="102.890625"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="129.777344" y="107.921875"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="141.167969" y="93.488281"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="145.75" y="93.390625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="150.742187" y="93.808594"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="108.746094" y="121.976562"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="131.03125" y="99.691406"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="153.628906" y="77.40625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="158.210938" y="77.308594"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="163.207031" y="77.726562"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="127.582031" y="51.675781"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="158.023438" y="59.832031"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="188.78125" y="67.988281"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="193.363281" y="67.890625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="198.355469" y="68.3125"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="197.882812" y="32.839844"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="203.09375" y="32.742188"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="182.664062" y="14.246094"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="187.242188" y="14.148437"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="192.238281" y="14.566406"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="159.753906" y="8.191406"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="164.964844" y="8.09375"/>
</g>
<g fill="rgb(19%, 31%, 97.000003%)" fill-opacity="1">
<use xlink:href="#glyph-0-4" x="92.574219" y="61.097656"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="97.457031" y="43.519531"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="102.039062" y="43.421875"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="107.03125" y="43.839844"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="75.171875" y="65.804688"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="67.28125" y="65.707031"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="72.277344" y="66.125"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="83.011719" y="96.242187"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="78.058594" y="96.144531"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="75.507812" y="118.003906"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="95.007812" y="192.625"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="87.117188" y="192.527344"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="92.113281" y="192.945312"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="108.746094" y="213.65625"/>
</g>
<g fill="rgb(100%, 5.1%, 5.1%)" fill-opacity="1">
<use xlink:href="#glyph-0-3" x="131.03125" y="235.941406"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="153.628906" y="258.226562"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="158.210938" y="258.128906"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="163.207031" y="258.546875"/>
</g>
<g fill="rgb(19%, 31%, 97.000003%)" fill-opacity="1">
<use xlink:href="#glyph-0-4" x="127.726562" y="283.957031"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="115.03125" y="296.824219"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="107.140625" y="296.726562"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="112.136719" y="297.144531"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-1" x="145.472656" y="288.664062"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-0-2" x="150.054687" y="288.566406"/>
</g>
<g fill="rgb(0%, 0%, 0%)" fill-opacity="1">
<use xlink:href="#glyph-1-1" x="155.050781" y="288.988281"/>
</g>
</svg>
)
